Skip to content
OpenCapital
Get started

Vir Biotechnology, Inc. VIR Q1 2026 earnings

Reported May 6, 2026 · After market close

Revenue-$29.0KMiss by $55.5M
EPS-$0.85Miss by $0.84
Revenue estimate$55.5M
EPS estimate-$0.01

Next report

Aug 5, 2026 (In 1 week)
Revenue estimate$135.9M
EPS estimate$0.33

Financials

Q1 2026

Income statement

See full
Revenue-$29.0K-101%
Operating income-$132.3M+5.2%
Net income-$125.7M-3.9%
EPS (diluted)-$0.85+3.4%

Balance sheet

See full
Cash & equivalents$283.0M-23.1%
Total debt$95.6M-0.5%
Total equity$812.8M-22.1%
Total assets$1.0B-21.6%

Cash flow

See full
Operating cash flow-$132.4M-69.5%
CapEx$390.0K-76.1%
Free cash flow-$132.8M-66.5%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$1.48B+95.9%
Enterprise value$1.3B+134%
P/S22.7×-17.2×

Profitability

See full
Operating margin-720.8%-313pp
Net margin-676%-291pp
FCF margin-686.5%-273pp

Returns & leverage

See full
Return on equity-47.7%+3.6pp
Debt / equity0.1×0.0×
Current ratio7.1×+0.3×

Versus estimates

Revenue

Q1 2026-$29.0KMiss by $55.5M
Q4 2025$64.1MBeat by $44.2MQ3 2025$240.0KMiss by $19.7MQ2 2025$1.2MMiss by $1.5MQ1 2025$1.8MMiss by $6.8MQ4 2024$12.4MBeat by $4.2M

Diluted EPS

Q1 2026-$0.85Miss by $0.84
Q4 2025-$0.31Beat by $0.11Q3 2025-$1.17Miss by $0.47Q2 2025-$0.80Miss by $0.08Q1 2025-$0.88Miss by $0.05Q4 2024-$0.76Beat by $0.09

Ask the moment Vir Biotechnology, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Vir Biotechnology, Inc. report Q1 2026 earnings?
Vir Biotechnology, Inc. (VIR) reported Q1 2026 earnings on May 6, 2026 after market close.
What were Vir Biotechnology, Inc.'s Q1 2026 revenue and EPS?
Vir Biotechnology, Inc. reported revenue of -$29.0K and eps of $-0.85 for Q1 2026.
Did Vir Biotechnology, Inc. beat estimates in Q1 2026?
Revenue missed the consensus estimate of $55.5M by $55.5M. EPS missed the consensus estimate of $-0.01 by $0.84.
How did Vir Biotechnology, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 101.6% from $1.8M a year earlier and eps grew 3.4% from $-0.88.
Where can I find Vir Biotechnology, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-031273) and the 10-Q periodic report (0001628280-26-031471) directly on SEC EDGAR. The filing index links above go to sec.gov.